Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II

See also
Status	Clinical Trial	Phase
Completed	`NCT01627808` - Fluid Optimization in Liver Surgery	N/A
Withdrawn	`NCT05109052` - Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma	Phase 1/Phase 2
Recruiting	`NCT05179824` - Tempus Priority Study: A Pan-tumor Observational Study
Recruiting	`NCT03896958` - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed	`NCT05030090` - Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer	N/A
Terminated	`NCT00669136` - Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma	Phase 1
Not yet recruiting	`NCT05041335` - Wet Heparinized Suction for Abdominal Cancer	N/A
Recruiting	`NCT04258813` - Onco-primary Care Networking to Support TEAM-based Care	N/A
Completed	`NCT03299036` - Drug-loadable（T-ACE Beads）for Hepatoma Embolization Therapy	N/A
Recruiting	`NCT03323996` - Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients	N/A
Not yet recruiting	`NCT06458998` - Getting To Implementation: Improving Cancer Screening for Veterans	N/A
Completed	`NCT02044224` - Effects of Dexmedetomidine During IRE Procedures for Solid Tumours	Phase 4
Not yet recruiting	`NCT03607643` - A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies	Phase 1/Phase 2
Completed	`NCT05643833` - Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
Recruiting	`NCT03452774` - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Not yet recruiting	`NCT03766776` - Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)	N/A
Completed	`NCT02016391` - Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours	Phase 4
Recruiting	`NCT00730860` - Treatment of Hepatocellular Carcinoma With Radiofrequency Ablation (RFA) Associated With Postoperative TACE	N/A
Terminated	`NCT00216437` - Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma	Phase 1
Completed	`NCT04172714` - Low-dose Y90 Treatment Planning for HCC	N/A

NCT number	NCT05907772
Study type	Observational
Source	Zhejiang University
Contact
Status	Completed
Phase
Start date	August 27, 2022
Completion date	November 10, 2022

Incorporation of Protein Induced by Vitamin K Absence or Antagonist-II Into Transplant Criteria Expands Beneficiaries of Liver Transplantation for Hepatocellular Carcinoma

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms